For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep, and goats. For the control of mortality associated with Escherichia coli organisms susceptible to neomycin sulfate in growing turkeys.